Monashee Investment Management’s The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 BODY.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding BODY.WS
ICM
PWAM
LA
PFM
AA
CH
GC
KC
AC
Monashee Investment Management's BODY.WS Position: Q4 2021 in Review
Monashee Investment Management sold out of The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (BODY.WS) in Q4 2021, closing a stake of 99,999 shares — an estimated $119K sold.
Monashee Investment Management first reported a position in BODY.WS in Q2 2021 and held it in 2 quarters. The position peaked at $298K in Q2 2021. 23 funds tracked by Wall St. Rank hold BODY.WS as of Q4 2021.
- Monashee Investment Management reported no remaining The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q4 2021 after selling out during the quarter.
- Monashee Investment Management sold 99,999 The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q4 2021, an estimated $119K.
- Monashee Investment Management first reported a position in The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q2 2021 and held it in 2 quarters.
- Monashee Investment Management's The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $298K in Q2 2021.
- 23 funds tracked by Wall St. Rank held The Beachbody Company, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q4 2021.
Based on Monashee Investment Management's 13F filing for Q4 2021, filed 7 Feb 2022.